PIK3CA and breast neoplasm: Researchers from the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial reported sequencing of the gene PIK3CA, which encodes the protein phosphatidylinositol 3-kinase, in oestrogen receptor positive breast tumours.